Donepezil for severe Alzheimer's disease.
Hogan
David B
DB
Division of Geriatric Medicine, University of Calgary Health Sciences Centre, Calgary, Alberta T2N 4N1, Canada. Electronic address: dhogan@ucalgary.ca.
D000203:Activities of Daily Living; D000544:Alzheimer Disease / Q000145:classification / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008134:Long-Term Care; D010352:Patient Dropouts; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012720:Severity of Illness Index
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil